Novel Biomarker Candidates to Predict Hepatic Fibrosis in Hepatitis C Identified by Serum Proteomics
- 17 May 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 56 (11), 3305-3315
- https://doi.org/10.1007/s10620-011-1745-4
Abstract
Background Liver biopsy remains the gold standard to assess hepatic fibrosis. It is desirable to predict hepatic fibrosis without the need for invasive liver biopsy. Proteomic techniques allow unbiased assessment of proteins and might be useful to identify proteins related to hepatic fibrosis. Aims We utilized two different proteomic methods to identify serum proteins as candidate biomarkers to predict hepatic fibrosis stage in patients with chronic hepatitis C virus (HCV) infection. Methods Serum was obtained from 24 people with chronic HCV at time of liver biopsy and from 6 normals. Liver biopsy fibrosis was staged 1–4 (Batts–Ludwig). Pooled serum samples (six in each of four fibrosis groups and controls) were analyzed with 4- and 8-plex isobaric tags for relative and absolute quantitation (iTRAQ), determining protein identification (ID) and ratios of relative protein abundance. Nonpooled samples were analyzed with two-dimensional (2-D) gels and difference in gel electrophoresis (DIGE) comparing different samples on the same gel and across gels. Spots varying among groups were measured with densitometry, excised, digested, and submitted for tandem mass spectrometry (MS/MS) protein ID. Results iTRAQ identified 305 proteins (minimum 99% ID confidence); 66 were increased or decreased compared with controls. Some proteins were increased or decreased for specific fibrosis scores. From 704 DIGE protein spots, 66 were chosen, 41 excised, and 135 proteins identified, since one gel spot often identified more than one protein. Conclusions Both proteomic methods identified two proteins as biomarker candidates for predicting hepatic fibrosis: complement C4-A and inter-alpha-trypsin inhibitor heavy chain H4.Keywords
This publication has 49 references indexed in Scilit:
- Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapiesHepatology, 2009
- Coagulation and fibrosis in chronic liver diseaseGut, 2008
- Liver cirrhosisThe Lancet, 2008
- Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markersHepatology, 2007
- Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective studyGut, 2007
- China takes centre stage for liver proteomeNature, 2003
- A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CHepatology, 2003
- The Human Plasma Proteome: History, Character, and Diagnostic ProspectsMolecular & Cellular Proteomics, 2003
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996
- Complications following percutaneous liver biopsyJournal of Hepatology, 1986